Refine by
Influenza A Vaccine Equipment & Supplies
16 equipment items found
Manufactured by:KM Biologics Co. Ltd. based inKumamoto, JAPAN
An inactivated quadrivalent split (HA) seasonal influenza vaccine produced using embryonated chicken eggs. The vaccine contains 15 μg or more of HA proteins for each strain per adult dose. The strains used to make the vaccine are decided by the MHLW each ...
Manufactured by:BioDiem Ltd. based inSouth Melbourne, AUSTRALIA
A core technology advantage: Live Attenuated Influenza Virus (LAIV) vaccine. BioDiem’s lead asset is the Live Attenuated Influenza Virus (LAIV) vaccine technology. Our LAIV vaccine licensing business involves out-licensing of the company’s platform technology to vaccine manufacturers ...
Manufactured by:BlueWillow Biologics based inAnn Arbor, MICHIGAN (USA)
BlueWillow’s intranasal vaccine technology has demonstrated safety and immunogenicity in Phase 1 clinical studies using a seasonal influenza vaccine. Several other ongoing BlueWillow programs — including intranasal vaccines for anthrax, pandemic influenza, RSV, HSV-2 and chlamydia — have ...
Manufactured by:Cure Pharmtech Co., Ltd based inGoyang-si, SOUTH KOREA
Ingredients: 1.6 mg (900 µg/m²) Thymosin alpha 1 per vial. 1.0 ml of sterile ...
Manufactured by:Novavax based inGaithersburg, MARYLAND (USA)
With the ongoing development of our NanoFlu™ and RSV F vaccines, a strong rationale exists for developing a combination respiratory vaccine that is designed to protect susceptible populations against both diseases. Although testing is at an early stage, we believe that a combination vaccine against both seasonal influenza ...
Manufactured by:Altimmune Inc. based inGaithersburg, MARYLAND (USA)
A recombinant intranasal vaccine that is being developed for both seasonal and pandemic use. NasoVAX can activate the humoral, mucosal and cellular immune arms in unison for a more comprehensive immune response. The data from our Phase 2a trial with a monovalent NasoVAX vaccine indicated that NasoVAX was well-tolerated and achieved 100% seroprotection with serum ...
Manufactured by:Athens Research & Technology Inc. based inAthens, GEORGIA (US) (USA)
IgA is the most abundant immunoglobulin in body fluids and the second most abundant immunoglobulin in plasma, found at a concentration of 0.4 to 2.2 mg/ml. It plays a very important role in the first specific defense against natural infection. Secretory IgA differs from serum IgA in that it contains two additional peptides: the secretory component and the J ...
Manufactured by:FluGen, Inc. based inMadison, WISCONSIN (USA)
The M2 Deleted Single Replication Live Virus Vaccine (M2SR) offers a potentially differentiating clinical value proposition. FluGen’s flu vaccine candidate works differently, stimulating mucosal, humoral, and cellular immunity, and offering unprecedented efficacy against infection and illness across seven years of virus drift, and documented steady immune response for at least six ...
Manufactured by:Menssana Research Inc. based inEdgewater, NEW JERSEY (USA)
Seasonal influenza is a common respiratory illness that presents with annual cough and fever epidemics. In the USA, the total economic burden of annual influenza epidemics amounted to $87.1 billion in 2003, arising mainly from outpatient visits, hospitalization, time lost from work, and premature death. The economic and clinical burdens of influenza epidemics may get worse in the future, because ...
Manufactured by:Boehringer Ingelheim Vetmedica, Inc. based inDuluth, GEORGIA (US) (USA)
Encephalomyelitis-Rhinopneumonitis-Influenza Vaccine; Influenza (Clade 1 and Clade 2), Herpes (EHV-1 and EHV-4) and Eastern & Western Encephalomyelitis killed virus, Tetanus ...
Manufactured by:Novavax based inGaithersburg, MARYLAND (USA)
In March 2020, we announced positive top-line results from our Phase 3 clinical trial of our nanoparticle seasonal quadrivalent influenza vaccine candidate, including our proprietary Matrix-M™ adjuvant (NanoFlu™). The trial was a randomized, observer-blinded, active-controlled trial in approximately 2,652 healthy older adults (aged 65 years and older) ...
Manufactured by:Boehringer Ingelheim Vetmedica, Inc. based inDuluth, GEORGIA (US) (USA)
Protects against EIV, EEE, WEE, tetanus and West Nile virus in 1 mL dose. At least six-month duration of immunity against equine influenza (Ohio/03). Ohio/03 (Florida Clade 1), Kentucky/95, and Richmond/07 (Florida Clade 2) equine influenza strains as recommended by the Expert Surveillance Panel on Equine Influenza. At least 12-month WNV DOI. ...
Manufactured by:CSL Seqirus UK Limited based inMaidenhead, UNITED KINGDOM
As a global leader in influenza protection, Seqirus has one of the broadest influenza vaccine portfolios in the world. In the Asia Pacific region we also provide access to a wide range of vaccines and specialty medicines that meet unique, local public health needs. Our broad range influenza ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
KIN1148, a small-molecule IRF3 agonist, is a novel influenza vaccine adjuvant found to enhance flu vaccine ...
Manufactured by:Altimmune Inc. based inGaithersburg, MARYLAND (USA)
Identical vector technology used for AdCOVID (COVID-19), NasoVAX (seasonal influenza) and NasoShield (anthrax) ...
by:Metaclipse Therapeutics Corporation based inAtlanta, GEORGIA (US) (USA)
Metaclipse Therapeutics Corporation is developing novel personalized vaccine immunotherapies for cancer. MembrexTM, a proprietary platform approach tailored to each patient and their specific tumor, consists of ‘membrane vesicles’ prepared from a patient’s tumor tissue that Metaclipse modifies with a ‘protein transfer’ method using proven immunostimulatory proteins. ...